Dana-Farber Apr 8, 2020 Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy Mar 31, 2020 Grail Multi-Cancer Test Meets Validation Goals; Patients to Receive Results Under New Pilot Aug 1, 2019 Dana Faber Cancer Institute, AroCell Evaluating Use of ELISA to Detect Cancer Marker Jul 24, 2019 Gray Foundation Awards $25M in Cancer Research Grants Jul 15, 2019 MSK Researchers Describe Clinical-Grade Deep Learning Approach to Assist Pathologists Premium Apr 3, 2019 Resolution Bio Liquid Biopsy Outperforms Guardant Test in Lung Cancer Gene Fusion Detection Premium Jan 25, 2019 Addario Institute, Dana-Farber Partner on Lung Cancer Sequencing Study Jan 24, 2019 Memorial Sloan Kettering Using Cerebral Spinal Fluid Liquid Biopsy, Sequencing to Track Glioma Evolution Premium Jul 6, 2018 Philips Begins Integration of Dana-Farber Clinical Pathways Into IntelliSpace Premium Nov 9, 2017 Biovica Eyes 2020 Commercial Launch for DiviTum Metastatic Breast Cancer Assay Premium Oct 24, 2016 Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
